Leprosy, Multibacillary: Clinical Trials

9 trials for Leprosy, Multibacillary, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed, 2 not yet recruiting, 2 recruiting, 1 no longer available. 3 Phase 2, 2 Not applicable, 1 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 23Completed 1, Not yet recruiting 1, Recruiting 1
Not applicable2Completed 1, Recruiting 1
Phase 41Completed 1

Follow Leprosy, Multibacillary: new trials by email Literature Review of Leprosy, Multibacillary trials Research Report on Leprosy, Multibacillary

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Telacebec in Adults With Multibacillary Leprosy (TEBULA Leprosy Trial)
Telacebec 300 mg, Telacebec 600 mg, Telacebec + Rifampicine - Leprosy, Multibacillary
Phase 2Not yet recruitingFondation Raoul Follereau1202026-12-012026-11-05
Epidemiological, Clinical, Diagnostic, and Therapeutic Characteristics of Hansen's Disease in Costa Rica (2018-2025)
Leprosy, Hansen's Disease
Not yet recruitingCaja Costarricense de Seguro Social1302026-05-012026-03-09
Accuracy of the Polymerase Chain Reaction of Ulnar Perineural Subcutaneous Aspirate Guided by Ultrasound for the Diagnosis and Monitoring of Leprosy Cure
Ultrasound-Guided Ulnar Perineural Subcutaneous Aspirate - Leprosy, Leprosy Neuropathy
Not applicableRecruitingUniversity of Brasilia1082026-01-012026-04-07
Serum Irisin Level In Leprosy Patients
Serum Irisin - Leprosy
CompletedAswan University582024-01-012024-11-08
Efficacy and Tolerability of Adjunct Metformin for Multibacillary Leprosy
Metformin, Placebo - Leprosy, Leprosy, Multibacillary
Phase 2RecruitingOxford University Clinical Research Unit Indonesia1662022-10-012025-08-07
A Study to Evaluate the Efficacy and Safety of Bedaquiline (TMC207) in Participants With Multibacillary Leprosy
Bedaquiline 200 mg - Leprosy, Multibacillary
Phase 2CompletedJanssen Research & Development, LLC112018-09-262024-02-02
Effect of Additional Clofazimine on Erythema Nodosum Leprosum (ENL) Reactions in Leprosy
Clofazimine, Placebo - Borderline Lepromatous Leprosy, Lepromatous Leprosy
Phase 4CompletedPaul Saunderson1002010-08-012015-06-04
Microcirculatory Impairment in Patients With Leprosy
acetylcholine Iontophoresis, sodium nitroprusside Iontophoresis - Lepromatous Leprosy
Not applicableCompletedCurt Treu202006-03-012014-03-12
Treatment Protocol for Clofazamine in the Long Term Treatment of Leprosy
clofazamine - Leprosy
No longer availableKaiser Permanente2015-04-03

Narrower conditions

Leprosy (8)  ·  Leprosy, Lepromatous (4)  ·  Leprosy, Tuberculoid (1)  ·  Mononeuropathies (1)  ·  Neglected Diseases (1)  ·  Neurologic Manifestations (1)  ·  Polyneuropathies (1)

Broader conditions

Actinomycetales Infections (9)  ·  Bacterial Infections (9)  ·  Bacterial Infections and Mycoses (9)  ·  Gram-Positive Bacterial Infections (9)  ·  Infections (9)  ·  Mycobacterium Infections (9)  ·  Mycobacterium Infections, Nontuberculous (9)  ·  Nervous System Diseases (2)  ·  Pathological Conditions, Signs and Symptoms (2)  ·  Disease Attributes (1)  ·  Leprosy (1)  ·  Leprosy, Paucibacillary (1)  ·  Neuromuscular Diseases (1)  ·  Pathologic Processes (1)

Interventions

Clofazimine (1)  ·  Metformin (1)  ·  Rifampin (1)  ·  Vitamins (1)  ·  bedaquiline (1)  ·  telacebec (1)

Sponsors

Aswan University (1)  ·  Caja Costarricense de Seguro Social (1)  ·  Curt Treu (1)  ·  Fondation Raoul Follereau (1)  ·  Janssen Research & Development, LLC (1)  ·  Kaiser Permanente (1)  ·  Oxford University Clinical Research Unit Indonesia (1)  ·  Paul Saunderson (1)  ·  University of Brasilia (1)

Countries

Brazil (2)  ·  Benin (1)  ·  Costa Rica (1)  ·  Egypt (1)  ·  Indonesia (1)  ·  Philippines (1)  ·  United States (1)

Top investigators

Arnold M Henson, MD (1)  ·  Eliete Bouskela, PhD (1)  ·  Hardiyanto Soebono, Prof.Dr.dr (1)  ·  Marivic Balagon, MD (1)  ·  Moustafa El Taieb, Professor (1)

Results publications

PMID 38808319, PMID 39665652